Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA
Journal of Clinical Virology, 05/08/2012
Jewett A et al. – Sensitive anti–HCV rapid assays are appropriate and feasible for high–prevalence, high–risk populations such as young persons who inject drugs (PWID).



